These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20002487)

  • 1. Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes.
    Akram K; Pedersen-Bjergaard U; Carstensen B; Borch-Johnsen K; Thorsteinsson B
    Diabet Med; 2009 Dec; 26(12):1306-8. PubMed ID: 20002487
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey.
    Akram K; Pedersen-Bjergaard U; Carstensen B; Borch-Johnsen K; Thorsteinsson B
    Diabet Med; 2006 Jul; 23(7):750-6. PubMed ID: 16842479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
    Kern W; Holstein A; Moenninghoff C; Kienhöfer J; Riedl M; Kulzer B
    Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
    Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
    Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
    Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
    Donnelly LA; Morris AD; Frier BM; Ellis JD; Donnan PT; Durrant R; Band MM; Reekie G; Leese GP;
    Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness.
    Henderson JN; Allen KV; Deary IJ; Frier BM
    Diabet Med; 2003 Dec; 20(12):1016-21. PubMed ID: 14632703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
    Halimi S
    Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
    Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
    Diabetes Res Clin Pract; 2017 Aug; 130():121-129. PubMed ID: 28602812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.
    Davis TME; Bruce DG; Finn J; Curtis BH; Barraclough H; Davis WA
    Diabetes Obes Metab; 2019 Mar; 21(3):648-657. PubMed ID: 30370611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.
    Rondags SM; de Wit M; Snoek FJ
    Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.
    Liatis S; Mylona M; Kalopita S; Papazafiropoulou A; Karamagkiolis S; Melidonis A; Xilomenos A; Ioannidis I; Kaltsas G; Lanaras L; Papas S; Basagiannis C; Kokkinos A
    Diabetes Metab; 2015 Apr; 41(2):126-31. PubMed ID: 25468446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12-month prospective observational study.
    Dunkley AJ; Fitzpatrick C; Gray LJ; Waheed G; Heller SR; Frier BM; Davies MJ; Khunti K;
    Diabetes Obes Metab; 2019 Jul; 21(7):1585-1595. PubMed ID: 30843327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mild hypoglycaemia is common in type 2 diabetic patients treated with insulin analogues in the Czech Republic and the patients are concerned about it: results of a GAPP2TM survey (Global Attitudes of Physicians and Patient)].
    Prázný M
    Vnitr Lek; 2015 Mar; 61(3):269-75. PubMed ID: 25873125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early hypoglycaemia and adherence after basal insulin initiation in a nationally representative sample of Medicare beneficiaries with type 2 diabetes.
    Li P; Geng Z; Ladage VP; Wu J; Lorincz I; Doshi JA
    Diabetes Obes Metab; 2019 Nov; 21(11):2486-2495. PubMed ID: 31297967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic hypoglycaemia in Type 1 diabetes: incidence and risk factors.
    Henriksen MM; Andersen HU; Thorsteinsson B; Pedersen-Bjergaard U
    Diabet Med; 2019 Jan; 36(1):62-69. PubMed ID: 30368899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies.
    Edridge CL; Dunkley AJ; Bodicoat DH; Rose TC; Gray LJ; Davies MJ; Khunti K
    PLoS One; 2015; 10(6):e0126427. PubMed ID: 26061690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus group study to identify the central facets of fear of hypoglycaemia in people with Type 2 diabetes mellitus.
    Grammes J; Stock W; Mann CG; Flynn EM; Kubiak T
    Diabet Med; 2017 Dec; 34(12):1765-1772. PubMed ID: 28856721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes.
    Schopman JE; Geddes J; Frier BM
    Diabetes Res Clin Pract; 2010 Jan; 87(1):64-8. PubMed ID: 19939489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.